InspireMD, Inc. , a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific.
Inspiremd stock last closed at $1.81, down 0.55% from the previous day, and has decreased 42.17% in one year. It has underperformed other stocks in the Medical Devices industry by 0.07 percentage points. Inspiremd stock is currently +13.84% from its 52-week low of $1.59, and -52.34% from its 52-week high of $3.80.
As of Dec 9, 2025, there are 42.37M shares of NSPR outstanding. The market value of NSPR is $76.69M. In the last 24 hours, 99,000 NSPR shares were traded.
You will need an online brokerage account to access the NASDAQ market and buy NSPR shares.
Based on our research, eToro is the best brokerage. eToro gives you:
Get $10 towards your share purchase by creating an account with eToro now. This offer is only for US users.
Open eToro AccountNow that you've chosen the right brokerage, the next step is to fill out some personal info so you are able to invest in NSPR today.
Now that you have finished signing up on stock market apps, your next step is to transfer the money for your investment:
Check out the walkthrough below if you need help depositing funds into your new investment account.
After you have chosen the best place to buy Inspiremd stock, it's critical to research their stock before you buy, so you actually wrap your head around the risk and upside.
WallStreetZen was created to help everyday investors do more in-depth fundamental analysis.
You can view all of the due diligence checks on NSPR's stock page.
You can use many financial metrics, analyses, models, and charts to gauge NSPR's true value.
Using relative valuations methods:
You can access more valuation research on NSPR's stock here.
You can dig deeper into what analysts are saying on the Inspiremd stock forecast page.
Last year, NSPR revenue was $7.78M. In the last 5 year, NSPR's revenue has gone up by 18.42% per year. This was faster than the Medical Devices industry average of 10.99%.
Learn more about NSPR's earnings and revenue performance here.
In the past 12 months, executives and large shareholders at NSPR have bought more shares than they have sold.
Paul Stuka, Director of NSPR, was the latest NSPR insider to buy. They bought $9,435.78 worth of NSPR stock on Dec 5, 2025.
Dig into more about who owns NSPR shares here.
No, Inspiremd doesn't provide an income stream by paying out dividends.
One of the major reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to find out what other traders have to say.
There are two primary order types:
Click the Open button and your broker will place the order.
If you need additional info about buying stocks on eToro, click the how to video below:
Now that you own some NSPR stock, you'll want to stay up-to-date on your new investment.
Start a watchlist to see the latest developments about your NSPR stock.
To reiterate, here are the 6 steps you need to take to buy Inspiremd stock right now:
If you need a brokerage account, eToro is our recommended venue.
Get Started with eToro TodayIf you would like to get the latest scoop on your investment in Inspiremd, create your watchlist below.